相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Superoxide Dismutase 1 in Health and Disease: How a Frontline Antioxidant Becomes Neurotoxic
Benjamin G. Trist et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2021)
Analysis of elimination half-lives in MamTKDB 1.0 related to bioaccumulation: Requirement of repeated administration and blood plasma values underrepresent tissues
Tim Hofer et al.
ENVIRONMENT INTERNATIONAL (2021)
The Role of Xenobiotics and Trace Metals in Parkinson's Disease
Geir Bjorklund et al.
MOLECULAR NEUROBIOLOGY (2020)
Generation of homogeneous midbrain organoids with in vivo-like cellular composition facilitates neurotoxin-based Parkinson's disease modeling
Tae Hwan Kwak et al.
STEM CELLS (2020)
Label-Free Nanoimaging of Neuromelanin in the Brain by Soft X-ray Spectromicroscopy
Jake Brooks et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)
The influence of iron on selected properties of synthetic pheomelanin
Andrzej Zadlo et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2020)
Characterization of the binding of tau imaging ligands to melanin-containing cells: putative off-target-binding site
Tetsuro Tago et al.
ANNALS OF NUCLEAR MEDICINE (2019)
Iron and other metals in the pathogenesis of Parkinson's disease: Toxic effects and possible detoxification
Geir Bjorklund et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2019)
Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases
Matthew J. Betts et al.
BRAIN (2019)
Neuromelanin, aging, and neuronal vulnerability in Parkinson's disease
Miquel Vila
MOVEMENT DISORDERS (2019)
Development of a Competition-Binding Assay to Determine Binding Affinity of Molecules to Neuromelanin via Fluorescence Spectroscopy
Jackson Fink et al.
BIOMOLECULES (2019)
Oxidative stress in the aging substantia nigra and the etiology of Parkinson's disease
Benjamin G. Trist et al.
AGING CELL (2019)
Impaired dopamine metabolism in Parkinson's disease pathogenesis
Anna Masato et al.
MOLECULAR NEURODEGENERATION (2019)
Animal Models for Parkinson's Disease Research: Trends in the 2000s
Kyohei Kin et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Dopamine, Oxidative Stress and Protein-Quinone Modifications in Parkinson's and Other Neurodegenerative Diseases
Enrico Monzani et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
Dose-Dependent Adult Neurodegeneration in a Rat Model After Neonatal Exposure to -N-Methylamino-l-Alanine
Laura Scott et al.
NEUROTOXICITY RESEARCH (2019)
Chemistry and Chemical Equilibrium Dynamics of BMAA and Its Carbamate Adducts
Pedro Diaz-parga et al.
NEUROTOXICITY RESEARCH (2018)
Cellular and Molecular Aspects of the -N-Methylamino-l-alanine (BMAA) Mode of Action within the Neurodegenerative Pathway: Facts and Controversy
Nicolas Delcourt et al.
TOXINS (2018)
Phosphorylated alpha-Synuclein Accumulations and Lewy Body-like Pathology Distributed in Parkinson's Disease-Related Brain Areas of Aged Rhesus Monkeys Treated with MPTP
Baihui Huang et al.
NEUROSCIENCE (2018)
Repeated five-day administration of L-BMAA, microcystin-LR, or as mixture, in adult C57BL/6 mice - lack of adverse cognitive effects
Oddvar Myhre et al.
SCIENTIFIC REPORTS (2018)
Selective vulnerability in neurodegenerative diseases
Hongjun Fu et al.
NATURE NEUROSCIENCE (2018)
Neuromelanin organelles are specialized autolysosomes that accumulate undegraded proteins and lipids in aging human brain and are likely involved in Parkinson's disease
Fabio A. Zucca et al.
NPJ PARKINSONS DISEASE (2018)
Synthesis, Structure Characterization, and Evaluation in Microglia Cultures of Neuromelanin Analogues Suitable for Modeling Parkinson's Disease
Emanuele Ferrari et al.
ACS CHEMICAL NEUROSCIENCE (2017)
Alzheimer's disease markers in the aged sheep (Ovis aries)
Suzanne J. Reid et al.
NEUROBIOLOGY OF AGING (2017)
Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease
Fabio A. Zucca et al.
PROGRESS IN NEUROBIOLOGY (2017)
Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson's disease
Lena F. Burbulla et al.
SCIENCE (2017)
Early life exposure to permethrin: a progressive animal model of Parkinson's disease
Cinzia Nasuti et al.
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS (2017)
Sheep recognize familiar and unfamiliar human faces from two-dimensional images
Franziska Knolle et al.
ROYAL SOCIETY OPEN SCIENCE (2017)
Structure of Human Tyrosinase Related Protein 1 Reveals a Binuclear Zinc Active Site Important for Melanogenesis
Xuelei Lai et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
Locus coeruleus volume and cell population changes during Alzheimer's disease progression: A stereological study in human postmortem brains with potential implication for early-stage biomarker discovery
Panos Theofilas et al.
ALZHEIMERS & DEMENTIA (2017)
Chronic and progressive Parkinson's disease MPTP model in adult and aged mice
Ana B. Munoz-Manchado et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Melanin and neuromelanin binding of drugs and chemicals: toxicological implications
Oskar Karlsson et al.
ARCHIVES OF TOXICOLOGY (2016)
The neurotoxicity of iron, copper and cobalt in Parkinson's disease through ROS-mediated mechanisms
A. P. Lan et al.
BIOMETALS (2016)
In vivo imaging of neuromelanin in Parkinson's disease using 18F-AV-1451 PET
Allan K. Hansen et al.
BRAIN (2016)
Neural Differentiation in the Third Dimension: Generating a Human Midbrain
Rebecca M. Marton et al.
CELL STEM CELL (2016)
Midbrain-like Organoids from Human Pluripotent Stem Cells Contain Functional Dopaminergic and Neuromelanin-Producing Neurons
Junghyun Jo et al.
CELL STEM CELL (2016)
Aminochrome induces dopaminergic neuronal dysfunction: a new animal model for Parkinson's disease
Andrea Herrera et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
Elemental mapping of Neuromelanin organelles of human Substantia Nigra: correlative ultrastructural and chemical analysis by analytical transmission electron microscopy and nano-secondary ion mass spectrometry
Antje Biesemeier et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Evolving basic, pathological and clinical concepts in PD
Lorraine V. Kalia et al.
NATURE REVIEWS NEUROLOGY (2016)
Saturation Binding of Nicotine to Synthetic Neuromelanin Demonstrated by Fluorescence Spectroscopy
Robert L. Haining et al.
NEUROCHEMICAL RESEARCH (2016)
Dietary exposure to an environmental toxin triggers neurofibrillary tangles and amyloid deposits in the brain
Paul Alan Cox et al.
PROCEEDINGS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2016)
Critical Analysis of the Melanogenic Pathway in Insects and Higher Animals
Manickam Sugumaran et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue
Marta Marquie et al.
ANNALS OF NEUROLOGY (2015)
Recent studies of ovine neuronal ceroid lipofuscinoses from BARN, the Batten Animal Research Network
David N. Palmer et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
Melanins and melanogenesis: from pigment cells to human health and technological applications
Marco d'Ischia et al.
PIGMENT CELL & MELANOMA RESEARCH (2015)
Structure-function correlations in tyrosinases
Margarita Kanteev et al.
PROTEIN SCIENCE (2015)
Polydopamine and Eumelanin: From Structure-Property Relationships to a Unified Tailoring Strategy
Marco d'Ischia et al.
ACCOUNTS OF CHEMICAL RESEARCH (2014)
The natural non-protein amino acid N-β-methylamino-L-alanine (BMAA) is incorporated into protein during synthesis
W. Broc Glover et al.
AMINO ACIDS (2014)
Neuromelanin of the Human Substantia Nigra: An Update
Fabio A. Zucca et al.
NEUROTOXICITY RESEARCH (2014)
Engineering of Midbrain Organoids Containing Long-Lived Dopaminergic Neurons
Vannary Tieng et al.
STEM CELLS AND DEVELOPMENT (2014)
MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration
Carolina Cebrian et al.
NATURE COMMUNICATIONS (2014)
Affinity Chromatography Method for Determination of Binding of Drugs to Melanin and Evaluation of Side Effect Potential of Antipsychotic Agents
Michal Piotr Marszall et al.
Current Pharmaceutical Analysis (2013)
Synthesis and structural characterization of soluble neuromelanin analogs provides important clues to its biosynthesis
Emanuele Ferrari et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2013)
Cerebral uptake and protein incorporation of cyanobacterial toxin β-N-methylamino-L-alanine
Xiaobin Xie et al.
NEUROREPORT (2013)
Metal Dyshomeostasis and Inflammation in Alzheimer's and Parkinson's Diseases: Possible Impact of Environmental Exposures
Oddvar Myhre et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2013)
The Non-Protein Amino Acid BMAA Is Misincorporated into Human Proteins in Place of L-Serine Causing Protein Misfolding and Aggregation
Rachael Anne Dunlop et al.
PLOS ONE (2013)
Eumelanin Buildup on the Nanoscale: Aggregate Growth/Assembly and Visible Absorption Development in Biomimetic 5,6-Dihydroxyindole Polymerization
Marianna Arzillo et al.
BIOMACROMOLECULES (2012)
Neuromelanins of Human Brain Have Soluble and Insoluble Components with Dolichols Attached to the Melanic Structure
Mireille Engelen et al.
PLOS ONE (2012)
Magnetic beads method for determination of binding of drugs to melanin
Michal Piotr Marszall et al.
JOURNAL OF CHROMATOGRAPHY A (2011)
Neuromelanin Activates Microglia and Induces Degeneration of Dopaminergic Neurons: Implications for Progression of Parkinson's Disease
Wei Zhang et al.
NEUROTOXICITY RESEARCH (2011)
An XAS study of the sulfur environment in human neuromelanin and its synthetic analogs
Pier Raimondo Crippa et al.
EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS (2010)
Iron and Other Metals in Neuromelanin, Substantia Nigra, and Putamen of Human Brain
Luigi Zecca et al.
JOURNAL OF NEUROCHEMISTRY (2010)
Neuromelanin inhibits CXCL10 expression in human astroglial cells
Neda Saffarian Tousi et al.
NEUROSCIENCE LETTERS (2010)
The substantia nigra pars compacta of the Gottingen minipig: an anatomical and stereological study
Mette Slot Nielsen et al.
BRAIN STRUCTURE & FUNCTION (2009)
Nicotine is neuroprotective when administered before but not after nigrostriatal damage in rats and monkeys
Luping Z. Huang et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Retention of the cyanobacterial neurotoxin β-N-methylamino-l-alanine in melanin and neuromelanin-containing cells - a possible link between Parkinson-dementia complex and pigmentary retinopathy
Oskar Karlsson et al.
PIGMENT CELL & MELANOMA RESEARCH (2009)
Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease
Luigi Zecca et al.
ACTA NEUROPATHOLOGICA (2008)
Intracellular Chemical Imaging of the Developmental Phases of Human Neuromelanin Using Synchrotron X-ray Microspectroscopy
Sylvain Bohic et al.
ANALYTICAL CHEMISTRY (2008)
Neuronal pigmented autophagic vacuoles: lipofuscin, neuromelanin, and ceroid as macroautophagic responses during aging and disease
David Sulzer et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Neuromelanin can protect against iron-mediated oxidative damage in system modeling iron overload of brain aging and Parkinson's disease
Luigi Zecca et al.
JOURNAL OF NEUROCHEMISTRY (2008)
New melanic pigments in the human brain that accumulate in aging and block environmental toxic metals
Luigi Zecca et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Biomedical applications of sheep models: from asthma to vaccines
Jean-Pierre Y. Scheerlinck et al.
TRENDS IN BIOTECHNOLOGY (2008)
Neurodegeneration of mouse nigrostriatal dopaminergic system induced by repeated oral administration of rotenone is prevented by 4-phenylbutyrate, a chemical chaperone
Masatoshi Inden et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
Michelle L. Block et al.
NATURE REVIEWS NEUROSCIENCE (2007)
The physical and chemical properties of eumelanin
Paul Meredith et al.
PIGMENT CELL RESEARCH (2006)
Whole-body lifetime occupational lead exposure and risk of Parkinson's disease
Steven Coon et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2006)
The surface oxidation potential of human neuromelanin reveals a spherical architecture with a pheomelanin core and a eumelanin surface
William D. Bush et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Neuromelanin and iron in human locus coeruleus and substantia nigra during aging: consequences for neuronal vulnerability
F. A. Zucca et al.
JOURNAL OF NEURAL TRANSMISSION (2006)
Parkinson's disease brain mitochondrial complex I has oxidatively damaged subunits and is functionally impaired and misassembled
Paula M. Keeney et al.
JOURNAL OF NEUROSCIENCE (2006)
Structures for amyloid fibrils
OS Makin et al.
FEBS JOURNAL (2005)
Synthesis and neurotoxicity of tetrahydroisoquinoline derivatives for studying Parkinson's disease
K Abe et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2005)
Diverse taxa of cyanobacteria produce β-N-methylamino-L-alanine, a neurotoxic amino acid
PA Cox et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Neuromelanin in human dopamine neurons: Comparison with peripheral melanins and relevance to Parkinson's disease
H Fedorow et al.
PROGRESS IN NEUROBIOLOGY (2005)
Long-term retention of neurotoxic β-carbolines in brain neuromelanin
A Östergren et al.
JOURNAL OF NEURAL TRANSMISSION (2004)
The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging
L Zecca et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Binding of 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4 oxobutyl]pyridinium ion (HPP+), a metabolite of haloperidol, to synthetic melanin: Implications for the dopaminergic neurotoxicity of HPP+
H Kawashima et al.
NEUROTOXICITY RESEARCH (2004)
Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains
K Imamura et al.
ACTA NEUROPATHOLOGICA (2003)
Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson's disease
BA Faucheux et al.
JOURNAL OF NEUROCHEMISTRY (2003)
The structure of neuromelanin as studied by chemical degradative methods
K Wakamatsu et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases
C Zarow et al.
ARCHIVES OF NEUROLOGY (2003)
Activation of microglia by human neuromelanin is NF-kappa B-dependent and involves p38 mitogen-activated protein kinase: implications for Parkinson's disease
H Wilms et al.
FASEB JOURNAL (2003)
Brain extraction of 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]pyridinium ion (HPP+), a neurotoxic metabolite of haloperidol:: Studies using [3H]HPP+
H Kawashima et al.
JAPANESE JOURNAL OF PHARMACOLOGY (2002)
Applications of affinity chromatography to the study of drug-melanin binding interactions
AF Aubry
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2002)
The absolute concentration of nigral neuromelanin, assayed by a new sensitive method, increases throughout the life and is dramatically decreased in Parkinson's disease
L Zecca et al.
FEBS LETTERS (2002)
Iron, neuromelanin and ferritin content in the substantia nigra of normal subjects at different ages:: consequences for iron storage and neurodegenerative processes
L Zecca et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Oxidation of 2 '-deoxyguanosine by H2O2-ascorbate: evidence against free OH. and thermodynamic support for two-electron reduction of H2O2
T Hofer
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 2 (2001)
Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles
D Sulzer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Interaction of human substantia nigra neuromelanin with lipids and peptides
L Zecca et al.
JOURNAL OF NEUROCHEMISTRY (2000)
分享论文
